Improving treatment and outcomes for children with leukaemia

Murray Norris

Professor Murray Norris AM

Children’s Cancer InstituteCancer Council NSW Funding: $2,249,946Funding duration: 2016-2020

Background

Despite the success in treating childhood leukaemia, it still remains one of the most common causes of death from disease in children in Australia.

The research

The aim of this 5 year program is to increase survival rates of children with Acute Lymphoblastic Leukaemia (ALL) and ultimately develop prevention strategies.

Specifically, this research focuses on developing new molecular targeted therapies for children with ALL which improve outcomes and have limited side effects.

The impact

Molecular therapies have enormous potential to significantly improve survival rates and quality of life for childhood survivors as they directly target the leukaemia cells while reducing the impact on healthy cells.


Learn more about:

Cancer information

Find information by cancer type.
Learn about symptoms, diagnosis and treatment for specific cancer types.

Want to know more about research at Cancer Council?
How we conduct research and how the community can get involved.

Cancer glossary.
Common cancer terms explained.

Support Services

Coping with cancer?
Speak to a qualified health professional or someone who has experienced cancer, access support groups & forums.

Need legal and financial assistance?
Find out how to access our Pro Bono Program for legal and financial advice.

Looking for transport, accommodation or home help?
Practical advice and support during and after treatment.

TOP BACK TO TOP